This application is for renewal of the core grant which has provided essential support for the research program of the Sloan-Kettering Institute for Cancer Research. This is a program of cancer research, many aspects of which are closely linked with the treatment activities of our sister organization, Memorial Hospital. The core grant has provided partial support of salaries of approximately 11% of the professional staff including most of the Institute's scientific leadership, and has underwritten supporting resources such as animal maintenance services, biostatistical management, instrumentation, and other centralized activities required by a large productive scientific organization. An important provision has been the financial support necessary to develop new programs. The core support has been crucial in helping to assure stability and give a degree of flexibility not available to the Institute from University or State funds.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA008748-27
Application #
3101254
Study Section
Special Emphasis Panel (SRC (15))
Project Start
1977-01-01
Project End
1992-12-31
Budget Start
1992-01-01
Budget End
1992-12-31
Support Year
27
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Seo, S K; Gedrimaite, Z; Paskovaty, A et al. (2018) Impact of QuickFISH in addition to antimicrobial stewardship on vancomycin use and resource utilization in cancer patients with coagulase-negative staphylococcal blood cultures. Clin Microbiol Infect 24:1339.e7-1339.e12
McDuff, Susan G R; Chen, Ming-Hui; Renshaw, Andrew A et al. (2018) Impact of time to testosterone rebound and comorbidity on the risk of cause-specific mortality in men with unfavorable-risk prostate cancer. Cancer 124:1391-1399
Sigel, Carlie S; Krauss Silva, Vitor Werneck; Reid, Michelle D et al. (2018) Well differentiated grade 3 pancreatic neuroendocrine tumors compared with related neoplasms: A morphologic study. Cancer Cytopathol 126:326-335
Fanale, Michelle A; Horwitz, Steven M; Forero-Torres, Andres et al. (2018) Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas. Blood 131:2120-2124
Barzilai, Ori; DiStefano, Natalie; Lis, Eric et al. (2018) Safety and utility of kyphoplasty prior to spine stereotactic radiosurgery for metastatic tumors: a clinical and dosimetric analysis. J Neurosurg Spine 28:72-78
Rosenberg, Jonathan B; Kaplitt, Michael G; De, Bishnu P et al. (2018) AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease. Hum Gene Ther Clin Dev 29:24-47
Ma, Jennifer; Lok, Benjamin H; Zong, Jingfeng et al. (2018) Proton Radiotherapy for Recurrent or Metastatic Head and Neck Cancers with Palliative Quad Shot. Int J Part Ther 4:10-19
Hieronymus, Haley; Murali, Rajmohan; Tin, Amy et al. (2018) Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death. Elife 7:
Garg, Angad; Goldgur, Yehuda; Schwer, Beate et al. (2018) Distinctive structural basis for DNA recognition by the fission yeast Zn2Cys6 transcription factor Pho7 and its role in phosphate homeostasis. Nucleic Acids Res 46:11262-11273
Scordo, Michael; Shah, Gunjan L; Kosuri, Satyajit et al. (2018) Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 24:133-141

Showing the most recent 10 out of 8799 publications